Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze

7680656510028 CH-65651 Injektionslösung
Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze
Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze
1 / 2
google

Article details

Package size
2
Selling units
2
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/09/2024
Summary of Product Characteristics
Français
13/09/2024
Summary of Product Characteristics
Italien
13/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
500.0 MG Substance HBESI
(N/A)
500.0 MG Substance HBESI
(N/A)
750.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
12.7 PVV Substance HBESI

Reimbursement information

Public price
CHF 329.05
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2016

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
65651
Drug name
Fulvestrant Sandoz, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L02BA03
Authorization status
Z
Dispensing category
B
First authorization
23/10/2015
Authorization expiration date
31/12/9999
IT Number
07.16.2.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
FULVESTRANT Sandoz 250 mg/5ml i.m. 2 ser pré 5 ml
Description (DE)
FULVESTRANT Sandoz 250 mg/5ml i.m. 2 Fertspr 5 ml
Market launch
23/10/2015
Narcotic (BTM)
No

Original drug

Faslodex, Injektionslösung
GTIN: 7680567780121
CHF 379.80
View original

Other package sizes (1)

FULVESTRANT Sandoz 250 mg/5ml i.m. ser pré 5 ml
None None
GTIN: 7680656510011
Not in V1